SMTL ID : 5ivz.2 (1 other biounit)

Cetuximab Fab in complex with Arg8Cir meditope variant

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.48 Å

Oligo State

hetero-1-1-1-mer

Ligands

2 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.1: 4 residues within 4Å: Chain A: R.39, R.45, P.59, R.61 7 PLIP interactions: 7 interactions with chain A Water bridges: A:Q.37, A:R.61, A:R.61, A:R.61 Salt bridges: A:R.39, A:R.45, A:R.61 PO4.2: 5 residues within 4Å: Chain A: T.164, E.165, D.167 Chain B: V.169, H.170 9 PLIP interactions: 3 interactions with chain B, 6 interactions with chain A Water bridges: B:H.170, B:H.170, A:E.165, A:E.165, A:S.168, A:S.168 Salt bridges: B:H.170 Hydrogen bonds: A:E.165, A:E.165

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bzymek, K.P. et al., Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun (2016)

Release Date

2016-10-26

Peptides

Cetuximab Fab, light chain: A
Cetuximab Fab, heavy chain: B
Meditope variant: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

C
F

Cetuximab Fab, light chain

Cetuximab Fab, heavy chain

Meditope variant

Related Entries With Identical Sequence